Thank you for your question. With Gleason 9 disease and SV involvement you are certainly a candidate for adjuvant radiation therapy. A recent study in 2008 showed that patients with pT3 disease had a lower risk of biochemical recurrence when treated with radiation following their prostatectomy.
In the early 1990s, 425 men were enrolled in SWOG (Southwest Oncology Group) 8794 with aggressive prostate cancer. They were randomly assigned within 16 weeks after prostatectomy into groups of adjuvant radiation or observation. Immediate radiation following the removal of the prostate significantly reduced recurrence (biochemical, local failure and metastatic disease) and increased metastatic disease-free and overall survival.
The Fifteen-year metastasis-free survival was 46 percent with radiation and 38 percent for observation respectively. The overall survival was 47 percent and 37 percent, respectively. Radiation therapy also significantly reduced biochemical and local failure as well as the need for androgen ablation (or hormone therapy).
A PSA rise at this point would not necessarily mean metastatic disease. It is not clear if distant micrometastases would evolve before PSA elevation. It could mean prostate tissue was left in the body (not necessarily a positive surgical margin but a capsular invasion) or micrometastases. It may be prudent for urinary function to return prior to starting radiation.
Best of luck
Ashutosh (Ash) K. Tewari, MD
www.cornellroboticprostate.org
This forum is for information only. The contents, such as graphics, images, text, quoted information and all other materials ("Content") are provided for reference only, do not claim to be complete or exhaustive or to be applicable to any particular individual's medical condition. Users should always consult with a qualified and licensed physician or other medical care provider. Users are warned to follow the advice of their physicians without delay regardless of anything read in this forum. The Weill Cornell Prostate Cancer Institute assumes no duty to correct or update the Content nor to resolve or clarify any inconsistent information which may be a part of the Content. Reliance on any Content is solely at the User's risk. This forum may contain health or medically related materials considered sexually explicit. Users are warned that if they may be offended by such Content, an alternate source of information should be found. Publication of information or reference in forum to specific sources such as specific products, procedures, physicians, treatments, or diagnoses are for information only and are not endorsements of the Weill Cornell Prostate Cancer Institute.
Sorry for the delay in response. Medhelp does not notify me when there are additions to threads.
There are several trials undergoing looking at adjuvant radiation with or without hormones:
http://clinicaltrials.gov/ct2/show/NCT00023829
It is important that related comorbidities of surgery are addressed prior to a radiation course. As radiation would only serve to exacerbate these symptoms.
Again, best of luck.
Ash
Thank you Dr. Tewari. You cited the SWOG 8794 study as showing adjuvant radiation reducing the need for androgen ablation. Are you aware of any evidence that hormone therapy combined with adjuvant radiation therapy increases the survival rate or extends the time to biochemical failure, local recurrence or metatastic disease? Is there any preparation that you recommend prior to treatment that can minimize side effects?
Thank you.